Fredén K, Vilén L, Lundborg P, Olsson L B, Kutti J
Scand J Haematol. 1979 Sep;23(3):245-50. doi: 10.1111/j.1600-0609.1979.tb02699.x.
Previous reports have shown that a single, oral dose of 50 mg metoprolol (a selective beta-1-receptor antagonist) causes a significant increase in the peripheral platelet count by releasing platelets from the spleen. In the present study 20 healthy volunteers received 50 mg metoprolol and 40 mg propranolol orally. Both drugs induced a statistically significant increase in the platelet count lasting more than 5 h. In addition, the effect of metoprolol and propranolol on beta-adrenoceptor mediated splenic platelet trapping was studied on 7 healthy subjects who received intravenous infusions of isoprenaline before and after the ingestion of these 2 beta-blocking drugs. It was demonstrated that the isoprenaline mediated decrease in the venous platelet count was diminished by both propranolol and metoprolol but the former compound appeared to be more potent in this respect. We conclude that both selective and non-selective beta-receptor blockade causes an increase in the peripheral platelet concentration during rest as well as during beta-adrenoceptor stimulation.
先前的报告显示,单次口服50毫克美托洛尔(一种选择性β-1受体拮抗剂)可通过使血小板从脾脏释放,导致外周血小板计数显著增加。在本研究中,20名健康志愿者口服了50毫克美托洛尔和40毫克普萘洛尔。两种药物均引起血小板计数的统计学显著增加,持续超过5小时。此外,在7名健康受试者中研究了美托洛尔和普萘洛尔对β-肾上腺素能受体介导的脾脏血小板捕获的影响,这些受试者在摄入这两种β受体阻滞剂之前和之后接受了异丙肾上腺素的静脉输注。结果表明,普萘洛尔和美托洛尔均减弱了异丙肾上腺素介导的静脉血小板计数的降低,但在这方面前一种化合物似乎更有效。我们得出结论,选择性和非选择性β受体阻滞剂在静息状态以及β-肾上腺素能受体刺激期间均会导致外周血小板浓度增加。